Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK0343 is an orally bioavailable GABAA receptor subtype-selective partial agonist and is a non-sedating anxiolytic.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 196.00 | |
25 mg | 6-8 weeks | $ 1,100.00 | |
50 mg | 6-8 weeks | $ 1,440.00 | |
100 mg | 6-8 weeks | $ 2,180.00 |
Description | MK0343 is an orally bioavailable GABAA receptor subtype-selective partial agonist and is a non-sedating anxiolytic. |
Targets&IC50 | GABAA α4 (rat):78 nM(ki), GABAA α6 (rat):980 nM(ki), GABAA α2 (rat):0.4 nM(ki), GABAA α3 (rat): 0.21 nM(ki), GABAA α5 (rat):0.23 nM(ki), GABAA α1 (rat):(ki)0.22 nM |
In vivo | MK0343 readily penetrates the brain in rats and occupies the benzodiazepine site of GABAA receptors, measured using an in vivo [3H]flumazenil binding assay. It has an Occ50 of 2.2?mg/kg p.o. and a corresponding plasma EC50 of 115?ng/mL . |
Synonyms | MRK-409 |
Molecular Weight | 397.38 |
Formula | C19H17F2N7O |
CAS No. | 233275-76-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-0343 233275-76-8 Others MRK-409 MRK 409 MRK409 MK 0343 MK0343 inhibitor inhibit